Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CTRV

ContraVir Pharmaceuticals

$0.53

-0.0398 (-6.98%)

, ABBV

AbbVie

$89.70

0.9 (1.01%)

04:55
11/13/18
11/13
04:55
11/13/18
04:55
Conference/Events
American Association of Liver Diseases to hold a meeting »

Liver Meeting 2018 will…

CTRV

ContraVir Pharmaceuticals

$0.53

-0.0398 (-6.98%)

ABBV

AbbVie

$89.70

0.9 (1.01%)

AGN

Allergan

$163.82

-1.77 (-1.07%)

ALXN

Alexion

$118.57

-4.88 (-3.95%)

BAYRY

Bayer

$0.00

(0.00%)

BOLD

Audentes Therapeutics

$23.60

-0.41 (-1.71%)

BMY

Bristol-Myers

$52.86

-0.54 (-1.01%)

BSX

Boston Scientific

$36.92

-1.68 (-4.35%)

CBAY

CymaBay

$10.49

-1.07 (-9.26%)

DOVA

Dova Pharmaceuticals

$16.52

-0.3803 (-2.25%)

DVAX

Dynavax

$12.17

0.09 (0.75%)

EXEL

Exelixis

$15.94

-0.72 (-4.32%)

ESALY

Eisai

$0.00

(0.00%)

GILD

Gilead

$70.49

-0.69 (-0.97%)

ICPT

Intercept

$100.79

-8.12 (-7.46%)

IQV

Iqvia

$121.10

-3.08 (-2.48%)

MRK

Merck

$74.68

-0.19 (-0.25%)

NVS

Novartis

$88.23

-0.98 (-1.10%)

NVO

Novo Nordisk

$44.55

-0.4 (-0.89%)

ONVO

Organovo

$1.12

-0.025 (-2.18%)

OSUR

OraSure

$13.49

0.475 (3.65%)

RCUS

Arcus Biosciences

$11.99

-0.31 (-2.52%)

RTRX

Retrophin

$24.80

-0.98 (-3.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 03

    Dec

  • 11

    Jan

  • 14

    Jan

  • 16

    Feb

  • 18

    Feb

  • 20

    May

  • 30

    Jun

Monday
CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

, ABBV

AbbVie

$88.80

1.07 (1.22%)

04:55
11/12/18
11/12
04:55
11/12/18
04:55
Conference/Events
American Association of Liver Diseases to hold a meeting »

Liver Meeting 2018 will…

CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

ABBV

AbbVie

$88.80

1.07 (1.22%)

AGN

Allergan

$165.59

-2.94 (-1.74%)

ALXN

Alexion

$123.45

-3.7 (-2.91%)

BAYRY

Bayer

$0.00

(0.00%)

BOLD

Audentes Therapeutics

$24.01

-0.93 (-3.73%)

BMY

Bristol-Myers

$53.40

0.59 (1.12%)

BSX

Boston Scientific

$38.60

0.17 (0.44%)

CBAY

CymaBay

$11.56

-0.18 (-1.53%)

DOVA

Dova Pharmaceuticals

$16.90

-2.38 (-12.34%)

DVAX

Dynavax

$12.08

-0.72 (-5.63%)

EXEL

Exelixis

$16.66

-0.46 (-2.69%)

ESALY

Eisai

$0.00

(0.00%)

GILD

Gilead

$71.18

-0.67 (-0.93%)

ICPT

Intercept

$108.91

-4.84 (-4.25%)

IQV

Iqvia

$124.18

-1.43 (-1.14%)

MRK

Merck

$74.87

-0.6 (-0.80%)

NVS

Novartis

$89.21

0.02 (0.02%)

NVO

Novo Nordisk

$44.95

0.275 (0.62%)

ONVO

Organovo

$1.15

(0.00%)

OSUR

OraSure

$13.01

-0.185 (-1.40%)

RCUS

Arcus Biosciences

$12.30

0.5 (4.24%)

RTRX

Retrophin

$25.78

-1.29 (-4.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 11

    Jan

  • 14

    Jan

  • 16

    Feb

  • 18

    Feb

  • 20

    May

Sunday
CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

, ABBV

AbbVie

$88.80

1.07 (1.22%)

04:55
11/11/18
11/11
04:55
11/11/18
04:55
Conference/Events
American Association of Liver Diseases to hold a meeting »

Liver Meeting 2018 will…

CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

ABBV

AbbVie

$88.80

1.07 (1.22%)

AGN

Allergan

$165.59

-2.94 (-1.74%)

ALXN

Alexion

$123.45

-3.7 (-2.91%)

BAYRY

Bayer

$0.00

(0.00%)

BOLD

Audentes Therapeutics

$24.01

-0.93 (-3.73%)

BMY

Bristol-Myers

$53.40

0.59 (1.12%)

BSX

Boston Scientific

$38.60

0.17 (0.44%)

CBAY

CymaBay

$11.56

-0.18 (-1.53%)

DOVA

Dova Pharmaceuticals

$16.90

-2.38 (-12.34%)

DVAX

Dynavax

$12.08

-0.72 (-5.63%)

EXEL

Exelixis

$16.66

-0.46 (-2.69%)

ESALY

Eisai

$0.00

(0.00%)

GILD

Gilead

$71.18

-0.67 (-0.93%)

ICPT

Intercept

$108.91

-4.84 (-4.25%)

IQV

Iqvia

$124.18

-1.43 (-1.14%)

MRK

Merck

$74.87

-0.6 (-0.80%)

NVS

Novartis

$89.21

0.02 (0.02%)

NVO

Novo Nordisk

$44.95

0.275 (0.62%)

ONVO

Organovo

$1.15

(0.00%)

OSUR

OraSure

$13.01

-0.185 (-1.40%)

RCUS

Arcus Biosciences

$12.30

0.5 (4.24%)

RTRX

Retrophin

$25.78

-1.29 (-4.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

  • 01

    Dec

  • 11

    Jan

  • 14

    Jan

  • 16

    Feb

  • 18

    Feb

  • 20

    May

Saturday
CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

, ABBV

AbbVie

$88.80

1.07 (1.22%)

04:55
11/10/18
11/10
04:55
11/10/18
04:55
Conference/Events
American Association of Liver Diseases to hold a meeting »

Liver Meeting 2018 will…

CTRV

ContraVir Pharmaceuticals

$0.57

-0.0499 (-8.05%)

ABBV

AbbVie

$88.80

1.07 (1.22%)

AGN

Allergan

$165.59

-2.94 (-1.74%)

ALXN

Alexion

$123.45

-3.7 (-2.91%)

BAYRY

Bayer

$0.00

(0.00%)

BOLD

Audentes Therapeutics

$24.01

-0.93 (-3.73%)

BMY

Bristol-Myers

$53.40

0.59 (1.12%)

BSX

Boston Scientific

$38.60

0.17 (0.44%)

CBAY

CymaBay

$11.56

-0.18 (-1.53%)

DOVA

Dova Pharmaceuticals

$16.90

-2.38 (-12.34%)

DVAX

Dynavax

$12.08

-0.72 (-5.63%)

EXEL

Exelixis

$16.66

-0.46 (-2.69%)

ESALY

Eisai

$0.00

(0.00%)

GILD

Gilead

$71.18

-0.67 (-0.93%)

ICPT

Intercept

$108.91

-4.84 (-4.25%)

IQV

Iqvia

$124.18

-1.43 (-1.14%)

MRK

Merck

$74.87

-0.6 (-0.80%)

NVS

Novartis

$89.21

0.02 (0.02%)

NVO

Novo Nordisk

$44.95

0.275 (0.62%)

ONVO

Organovo

$1.15

(0.00%)

OSUR

OraSure

$13.01

-0.185 (-1.40%)

RCUS

Arcus Biosciences

$12.30

0.5 (4.24%)

RTRX

Retrophin

$25.78

-1.29 (-4.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

  • 01

    Dec

  • 11

    Jan

  • 14

    Jan

  • 16

    Feb

  • 18

    Feb

  • 20

    May

Friday
BMY

Bristol-Myers

$52.75

-0.06 (-0.11%)

12:03
11/09/18
11/09
12:03
11/09/18
12:03
Hot Stocks
Bristol-Myers granted orphan status for lung cancer treatment »

The FDA, according to a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 12

    Nov

  • 20

    May

CTRV

ContraVir Pharmaceuticals

$0.62

0.0685 (12.42%)

, ABBV

AbbVie

$87.73

0.75 (0.86%)

08:30
11/09/18
11/09
08:30
11/09/18
08:30
Conference/Events
American Association of Liver Diseases to hold a meeting »

Liver Meeting 2018 will…

CTRV

ContraVir Pharmaceuticals

$0.62

0.0685 (12.42%)

ABBV

AbbVie

$87.73

0.75 (0.86%)

AGN

Allergan

$168.53

-0.39 (-0.23%)

ALXN

Alexion

$127.15

0.01 (0.01%)

BAYRY

Bayer

$0.00

(0.00%)

BOLD

Audentes Therapeutics

$24.94

0.72 (2.97%)

BMY

Bristol-Myers

$52.81

-0.19 (-0.36%)

BSX

Boston Scientific

$38.43

0.49 (1.29%)

CBAY

CymaBay

$11.74

0.08 (0.69%)

DOVA

Dova Pharmaceuticals

$19.28

0.555 (2.96%)

DVAX

Dynavax

$12.80

0.72 (5.96%)

EXEL

Exelixis

$17.12

-0.2 (-1.15%)

ESALY

Eisai

$0.00

(0.00%)

GILD

Gilead

$71.85

-0.6 (-0.83%)

ICPT

Intercept

$113.75

-0.81 (-0.71%)

IQV

Iqvia

$125.61

-1.07 (-0.84%)

MRK

Merck

$75.47

0.43 (0.57%)

NVS

Novartis

$89.19

0.32 (0.36%)

NVO

Novo Nordisk

$44.67

0.12 (0.27%)

ONVO

Organovo

$1.15

0.025 (2.23%)

OSUR

OraSure

$13.20

-1.535 (-10.42%)

RCUS

Arcus Biosciences

$11.80

0.55 (4.89%)

RTRX

Retrophin

$27.07

-0.09 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 09

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 27

    Nov

  • 01

    Dec

  • 11

    Jan

  • 14

    Jan

  • 16

    Feb

  • 18

    Feb

  • 20

    May

Over a week ago
NKTR

Nektar

$37.89

1.83 (5.07%)

, BMY

Bristol-Myers

$53.00

1.66 (3.23%)

08:46
11/08/18
11/08
08:46
11/08/18
08:46
Recommendations
Nektar, Bristol-Myers analyst commentary at Jefferies »

Nektar price target…

NKTR

Nektar

$37.89

1.83 (5.07%)

BMY

Bristol-Myers

$53.00

1.66 (3.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 27

    Nov

  • 20

    May

BMY

Bristol-Myers

$51.34

-0.68 (-1.31%)

16:35
11/06/18
11/06
16:35
11/06/18
16:35
Hot Stocks
Bristol-Myers says FDA approves Empliciti plus pomalidomide and dexamethasone »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 12

    Nov

  • 20

    May

ONCS

OncoSec

$1.82

-0.05 (-2.67%)

, MRK

Merck

$73.29

1.085 (1.50%)

13:53
11/05/18
11/05
13:53
11/05/18
13:53
Hot Stocks
OncoSec CEO says non-responder definitive criteria makes '695 study unique »

In an exclusive interview…

ONCS

OncoSec

$1.82

-0.05 (-2.67%)

MRK

Merck

$73.29

1.085 (1.50%)

BMY

Bristol-Myers

$51.99

1.32 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 20

    May

NKTR

Nektar

$39.01

-1.69 (-4.15%)

, BMY

Bristol-Myers

$50.67

-1.46 (-2.80%)

07:12
11/05/18
11/05
07:12
11/05/18
07:12
Recommendations
Nektar, Bristol-Myers analyst commentary at H.C. Wainwright »

Nektar price target…

NKTR

Nektar

$39.01

-1.69 (-4.15%)

BMY

Bristol-Myers

$50.67

-1.46 (-2.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

  • 10

    Nov

  • 12

    Nov

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.